Showing 1 - 2 results of 2 for search 'I. Lal', query time: 0.02s
Refine Results
-
1
S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE... by N. G. Daver, P. Vyas, S. Kambhampati, M. M. Al Malki, R. Larson, A. Asch, G. Mannis, W. Chai-Ho, T. Tanaka, T. Bradley, D. Jeyakumar, E. Wang, G. Xing, M. Chao, G. Ramsingh, C. Renard, I. Lal, J. Zeidner, D. Sallman
Published 2022-06-01
Article -
2
S166: MAGROLIMAB IN COMBINATION WITH AZACITIDINE FOR PATIENTS WITH UNTREATED HIGHER-RISK MYELODYSPLASTIC SYNDROMES (HR MDS): 5F9005 PHASE 1B STUDY RESULTS by D. A. Sallman, M. M. Al Malki, A. S. Asch, E. S. Wang, J. G. Jurcic, T. J. Bradley, I. W. Flinn, D. A. Pollyea, S. N. Kambhampati, T. N. Tanaka, J. F. Zeidner, G. Garcia-Manero, D. Jeyakumar, L. Gu, A. Tan, M. Chao, C. O’Hear, I. Lal, P. Vyas, N. Daver
Published 2022-06-01
Article